Fennec Pharmaceuticals Inc. · NASDAQ:FENC

Andrade Robert exercised options for 29,207 Fennec Pharmaceuticals Inc. shares (Form 4)

Traded Mar 28 to Mar 31, 2026 · Filed Apr 2, 2026

From Mar 28 to Mar 31, 2026, Andrade Robert (CHIEF FINANCIAL OFFICER) exercised options for 29,207 Fennec Pharmaceuticals Inc. shares, leaving 273,593 shares. Filed Apr 2, 2026 (Form 4).

Options exercised
29,207 shares
Holding after
273,593 shares
Trading plan
No
Role
CHIEF FINANCIAL OFFICER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Mar 28, 2026Common sharesOption exercise12,270285,863Direct
Mar 31, 2026Common sharesOption exercise14,724271,380Direct
Mar 31, 2026Common sharesOption exercise2,213273,593Direct

Source

View original at SEC

Related